(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REPERTOIRE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

REPERTOIRE

ST13

US500000088774013

Class

5

Filing

88774013

Registration

6303018

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

03/24/2026

Trademark type

Word

Nice classes

5

Filing date

01/27/2020

Registration date

03/23/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/23/2021

Last transaction

03/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

2020-12-00

First use in commerce

2020-12-00

Drawing code

4

Owner type

03

Owner location

CAMBRIDGE, MA, US

Examiner

YOUNG, THOMAS PAUL

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

REPERTOIRE IMMUNE MEDICINES, INC.
Cogen Immune Medicine, Inc.

Representatives

CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

therapeutic products for medical purposes in the nature of biological preparationsbiological tissue cultures and cell-based therapeutics in the nature of genetically modified cells used to modulate an immune response; pharmaceutical preparations used to modulate an immune response; pharmaceuticals and medical preparations for immunotherapycell therapyimmune cell therapyT-cell therapy for use in the prevention and treatment of cancertumorsdiseases and disorders of the immune system; pharmaceuticals and medical preparations for use in the prevention and treatment of cancertumorsdiseases and disorders of the immune system; pharmaceuticals and medical preparations in the nature of biotherapeuticsimmunotherapeuticsimmunomodulatorsimmunostimulantsimmunogenicsantibodiescell therapeuticscellsimmune cellsT-cells for use in the prevention and treatment of cancertumorsdiseases and disorders of the immune system

Publications

History of USPTO decisions and trademark events.

34 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/23/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/07/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/07/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/07/2025

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

03/23/2021

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/12/2021

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

02/12/2021

ALIE

ASSIGNED TO LIE

02/11/2021

EXPT

EXPARTE APPEAL TERMINATED

02/11/2021

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

02/11/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

02/11/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/11/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

02/11/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/11/2021

IUAA

USE AMENDMENT ACCEPTED

02/11/2021

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

02/04/2021

IUAF

USE AMENDMENT FILED

02/04/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

02/03/2021

EAAU

TEAS AMENDMENT OF USE RECEIVED

02/03/2021

EXPI

EX PARTE APPEAL-INSTITUTED

02/03/2021

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

02/03/2021

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

02/03/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/03/2020

GNFR

FINAL REFUSAL E-MAILED

08/03/2020

CNFR

FINAL REFUSAL WRITTEN

08/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/15/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/14/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/14/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/21/2020

GNRT

NON-FINAL ACTION E-MAILED

04/21/2020

CNRT

NON-FINAL ACTION WRITTEN

04/21/2020

DOCK

ASSIGNED TO EXAMINER

04/15/2020

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/08/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/30/2020

Continuous trademark protection

Get notified about every new filing that threatens REPERTOIRE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.